Novel biomarkers of coronary microvascular disease.
Coronary microvascular disease in the absence of myocardial diseases has traditionally been diagnosed through coronary reactivity testing in the cardiac catheterization laboratory. Compared with invasive procedures, blood-based biomarkers may have reduced cost, less risk of physical harm and greater accessibility, making them ideal for an outpatient management strategy. There are a variety of biomarkers available with potential utility in the management of microvascular disease; however, none have yet been extensively validated or established in this clinical patient population.
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Olivia Y
OY
Hung
Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Suegene K
SK
Lee
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Parham
P
Eshtehardi
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Habib
H
Samady
D015415:Biomarkers / Q000097:blood*; D003324:Coronary Artery Disease / Q000097:blood* / Q000175:diagnosis; D003326:Coronary Circulation; D006801:Humans; D055806:Microvessels
D015415:Biomarkers
biomarkers; coronary flow reserve; coronary microvascular disease